TUBB8P9

Across TCGA pan-cancer cohorts, TUBB8P9 RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated TUBB8P9 data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher TUBB8P9 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated TUBB8P9 expression acts as an unfavorable survival marker, although some lineages such as SKCM and LUSC show a favorable association.

BLCA, KIRC, and BRCA are the cancer types where TUBB8P9 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	DFS	Tertile	II,III,IV	0.489	0.634	.004	75	view →
KIRC	DFS	Tertile	III,IV	0.416	0.677	.002	72	view →
BRCA	DFS	Tertile	All	0.863	0.914	<.001	51	view →
LIHC	DFS	Tertile	III,IV	0.088	0.437	<.001	51	view →
LUAD	DFS	Tertile	IV	0.384	0.743	<.001	36	view →
ACC	OS	Tertile	All	0.369	0.708	.008	31	view →
LGG	OS	Tertile	All	0.848	0.910	.003	30	view →
SKCM	DFS	Tertile	IV	0.954	0.182	.014	27	view →
READ	DFS	Tertile	All	0.182	0.798	.010	27	view →
LUSC	DFS	Tertile	III,IV	0.737	0.243	.011	12	view →
SARC	DFS	Tertile	All	0.710	0.489	.019	9	view →
LAML	DFS	Tertile	All	0.666	0.301	.014	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 15 lineages.

TUBB8P9–BLCA (DFS)

Open the BLCA breakdown →